MAPT and Alzheimer disease: Among the most studied biomarkers, amyloid-beta 42 (Aβ42) and phosphorylated tau (p-tau) have emerged as core indicators of AD [5] as they accurately reflect the neuropathological hallmarks of the disease [6–8].